Loading clinical trials...
Loading clinical trials...
The aim of the study is to evaluate early safety, clinical efficacy and long-term outcomes of mitral allografts and stented biological prosthesis in tricuspid valve replacement for primary tricuspid v...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Chelyabinsk Regional Clinical Hospital
NCT07333495 · Kidney Transplant, Renal Allograft Recipients, and more
NCT07267117 · Heart Valve Disease, Mitral Valve (MV) Regurgitation, and more
NCT05797519 · Tricuspid Regurgitation, Tricuspid Valve Disease, and more
NCT05742906 · Tricuspid Valve Disease, Tricuspid Valve Insufficiency
NCT06137807 · Tricuspid Regurgitation, Tricuspid Valve Disease
Department of Cardiac Surgery
Chelyabinsk
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions